
The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting

News
2025.05.28
*Information* Seminar co-hosted with the Department of Systems Bioinformatics on June 17

News
2025.05.26
*Information* Why can newts “super-regenerate”? Molecular Mechanisms of Organ Regeneration will be held on June 10.
.png)
News
2025.05.23
*Information* We will hold an in-house seminar “Development of Gastroenterological, Breast and Endocrine Surgery” on Tuesday, June 17
.png)
News
2025.04.23
*Announcement* Phase I/IIa Clinical Trial of Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) Transplantation in Neovascular Age-Related Macular Degeneration Refractory to Existing Treatments (Trial Title: PRESERVE Study)

News
2025.04.04
*Announcement* Crowdfunding Goal Reached

News
2025.03.28
*Report* Open Seminar of the Division of Advanced Genome Editing Therapy was held.

News
2025.02.26
*Announcement* Presentation at the Lunch Meeting of the Research Institute and Center Conference

News
2025.02.13
*Notice* Currently exhibiting at the Osaka-Kansai Expo pre-event!

Thesis
2025.05.19
Two distinct mechanisms of PP2A regulation by methylesterase PME-1 are both essential for mouse development

Thesis
2025.04.17
Pilot study of autologous multilayered fibroblast sheet transplantation for reinforcing bronchial stump healing after pulmonary lobectomy in a canine model

Thesis
2025.04.08
Innovative Treatment of Ankylosing Dystrophy with a Novel RNA-Targeted Protein

Thesis
2025.03.03
Sodium ferrous citrate in 5-Aminolevulinic acid supplements suppresses the effector function of feline lymphocytes by reducing the mitochondrial membrane potential

Thesis
2025.02.05
Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease

Thesis
2025.01.27
Pharmacokinetics of Hydrogen During Hydrogen-Saturated Saline Infusion in Pigs

Thesis
2025.01.16
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced Cardiomyopathy

Thesis
2024.12.13
Establishment of a novel amyotrophic lateral sclerosis patient (TARDBP N345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.
The article could not be found.

News
2025.05.28
*Information* Seminar co-hosted with the Department of Systems Bioinformatics on June 17

News
2025.05.26
*Information* Why can newts “super-regenerate”? Molecular Mechanisms of Organ Regeneration will be held on June 10.
.png)
News
2025.05.23
*Information* We will hold an in-house seminar “Development of Gastroenterological, Breast and Endocrine Surgery” on Tuesday, June 17

Thesis
2025.05.19
Two distinct mechanisms of PP2A regulation by methylesterase PME-1 are both essential for mouse development
.png)
News
2025.04.23
*Announcement* Phase I/IIa Clinical Trial of Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) Transplantation in Neovascular Age-Related Macular Degeneration Refractory to Existing Treatments (Trial Title: PRESERVE Study)

Thesis
2025.04.17
Pilot study of autologous multilayered fibroblast sheet transplantation for reinforcing bronchial stump healing after pulmonary lobectomy in a canine model

Thesis
2025.04.08
Innovative Treatment of Ankylosing Dystrophy with a Novel RNA-Targeted Protein

News
2025.04.04
*Announcement* Crowdfunding Goal Reached
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー